6012 The FIRIS study; A Phase III trial of 5-FU/l-leucovorin/irinotecan (FOLFIRI) versus irinotecan/S-1 (IRIS) as 2nd-line chemotherapy for metastatic colorectal cancer (mCRC) [FIRIS study group]

✍ Scribed by Kato, K.; Muro, K.; Yasui, H.; Tsuji, A.; Sameshima, S.; Baba, H.; Satoh, T.; Denda, T.; Ina, K.; Sugihara, K.

• Book ID: 122388410
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 65 KB
• Volume: 7
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/S1359-6349(09)71107-3